mRNA COVID-19 vaccines – Communicable Diseases Research

Divergent SARS-CoV-2-specific T cell responses in intensive care unit workers following mRNA COVID-19 vaccination

Article

Published on 2022-10-062022-11-15
Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 진단,

Constrictive pericarditis following inactivated virus COVID-19 vaccine: a case report with review of the literature

Case report

Published on 2022-10-012022-10-05
Journal: Radiology Case Reports [Category] 진단,

Robust T-Cell Responses in Anti-CD20-Treated Patients Following COVID-19 Vaccination: A Prospective Cohort Study

COVID-19 백신 접종 후 항-CD20 치료 환자의 강력한 T-세포 반응: 전향적 코호트 연구

Observational Study

Published on 2022-08-242022-09-11
Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 임상, 진단, 치료기술,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus anti-CD20 anti-CD20 therapy anti-CD20 treatment antibodies antibody Antibody Response Arthritis Breakthrough infection CD20 CD4 CD4 T cell CD8 T cell CD8 T cells cohort study Complication Control controls coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 vaccination COVID-19 vaccine detectable dose Effectiveness effector molecule effector molecules expressed Follow-up had no humoral humoral responses individual Mild mRNA COVID-19 vaccines mRNA-based COVID-19 vaccine multiple sclerosis Ocrelizumab Patient patients treated Prospective prospective observational cohort reduction respiratory response response rate response rates rheumatic disease Rheumatic diseases rheumatoid arthritis risk rituximab seroconverted severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 severe coronavirus disease severe COVID-19 significantly lower specific antibodies spike T cell T cells T-cell T-cell Response T-cell responses Th1 phenotype treated treated patient vaccination
[DOI] 10.1093/cid/ciab954 PMC 바로가기 [Article Type] Observational Study

Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort

진행중인 미코페놀레이트 치료는 만성 염증성 자가면역 질환 또는 간 이식 수혜자의 영향을 받는 환자에서 항-SARS-CoV-2 백신 반응을 손상시킵니다: RIVALSA 예상 코호트의 결과

Observational Study

Published on 2022-08-122022-09-11
Journal: Viruses [Category] SARS, 임상, 진단, 치료기술,

[키워드] 95% CI administration Analysis anti-SARS-CoV-2 anti-SARS-CoV-2 antibody anti-SARS-CoV-2 IgG anti-SARS-CoV-2 vaccination Antibody Response Antibody titers ARMS Arthritis Autoimmune Autoimmune disease Autoimmune diseases Autoimmune hepatitis calcineurin calcineurin inhibitors chronic cohort of patients Complete connective tissue disease Connective tissue diseases detectable develop Diagnosis dose dose reduction Effect effective Eligible patients enrolled evaluate evaluated example first dose healthy subjects hepatology identify IgG immunogenicity immunosuppressive immunosuppressive therapy Immunosuppressive treatment independent predictor independent predictors individual inhibitor liver liver transplant Liver transplantation MMF mRNA COVID-19 vaccine mRNA COVID-19 vaccines mRNA vaccine mRNA-based Multivariate analysis mycophenolate mycophenolate. neoplasia Novara observational study organ other diseases overlapped Patient patients performed predictor Prevent Prospective prospective observational study receiving recipients rejection required response Result rheumatoid arthritis rheumatological SARS-COV-2 infection selected Seroconversion seroconversion failure spondyloarthritis subgroups of patient suffered Suspension Tertiary therapy transplantation transplants treated Treatment unit Univariate analysis university vaccinated individual vaccination Vaccine vaccine response Vasculitis
[DOI] 10.3390/v14081766 PMC 바로가기 [Article Type] Observational Study

Monitoring Anti-PEG Antibodies Level upon Repeated Lipid Nanoparticle-Based COVID-19 Vaccine Administration

반복적인 지질 나노입자 기반 COVID-19 백신 투여 시 항-PEG 항체 수준 모니터링

Article

Published on 2022-08-092022-09-12
Journal: International Journal of Molecular Sciences [Category] 진단,

Safety and tolerability of SARS-Cov-2 vaccination in patients with myasthenia gravis: A multicenter experience

중증 근무력증 환자에서 SARS-Cov-2 백신 접종의 안전성 및 내약성: 다기관 경험

Multicenter Study

Published on 2022-08-012022-09-12
Journal: European journal of neurology [Category] COVID19(2023년), SARS, 진단,

Effectiveness of 2, 3, and 4 COVID-19 mRNA Vaccine Doses Among Immunocompetent Adults During Periods when SARS-CoV-2 Omicron BA.1 and BA.2/BA.2.12.1 Sublineages Predominated – VISION Network, 10 States, December 2021-June 2022

SARS-CoV-2 Omicron BA.1 및 BA.2/BA.2.12.1 하위 계통이 우세한 기간 동안 면역적격 성인 중 2, 3 및 4 COVID-19 mRNA 백신 용량의 효과 - VISION Network, 10개 주, 2021년 12월 -2022년 6월

Article

Published on 2022-07-222022-09-11
Journal: Morbidity and Mortality Weekly Report [Category] COVID19(2023년), SARS, 변종,

Effectiveness of a fourth dose of covid-19 mRNA vaccine against the omicron variant among long term care residents in Ontario, Canada: test negative design study

캐나다 온타리오주 장기요양원에서 오미크론 변이에 대한 covid-19 mRNA 백신 4차 접종의 효과: 음성 설계 연구 테스트

Article

Published on 2022-07-062022-09-11
Journal: The BMJ [Category] COVID19(2023년), SARS, 변종,

[키워드] 95% confidence interval BNT162b2 Canada Care Chain Reaction Characteristics Comorbidities Control death dominant dose doses Effectiveness Hospital admission Infection Logistic regression long term mRNA mRNA COVID-19 vaccines mRNA vaccine mRNA-1273 multivariable logistic regression Older Omicron variant outcome outcomes polymerase chain polymerase chain reaction positive recipient reverse transcription reverse transcription polymerase chain reaction RT-PCR SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 test Seven symptomatic symptomatic infection Test test negative test result tested the vaccine vaccination Vaccine vaccine dose was used
[DOI] 10.1136/bmj-2022-071502 PMC 바로가기 [Article Type] Article

Evaluation of humoral and cellular response to third dose of BNT162b2 mRNA COVID-19 vaccine in patients treated with B-cell depleting therapy

B세포 고갈 요법으로 치료받은 환자에서 BNT162b2 mRNA COVID-19 백신 3차 접종에 대한 체액 및 세포 반응 평가

Article

Published on 2022-07-012022-09-11
Journal: Journal of autoimmunity [Category] MERS, 바이오마커, 유전자 메커니즘, 진단,

[키워드] affected anti-CD20 anti-S anti-SARS-CoV-2 antibody Autoimmune disease B-cell BNT162b2 CD-20 CD20 cellular immunity cellular response Cohort COVID-19 COVID-19 vaccination COVID-19 vaccine depleting dose doses drug group healthy control healthy controls humoral humoral and cellular immunity IFN-g IgG IMID Immune-mediated inflammatory disease Immune-mediated inflammatory diseases immunogenic immunogenicity Immunosuppressed immunosuppressed patient immunosuppressed patients Inflammatory diseases interferon mRNA mRNA COVID-19 vaccine mRNA COVID-19 vaccines naïve Neutralization assay neutralization assays neutralization titer neutralization titers Neutralizing antibodies neutralizing antibody no significant difference of BNT162b2 Patient patients treated Quantitative reduced response seroconverted significant difference significantly spike subject therapy These data treated vaccination
[DOI] 10.1016/j.jaut.2022.102848 PMC 바로가기 [Article Type] Article

mRNA COVID-19 vaccine effectiveness against SARS-CoV-2 infection in a prospective community cohort, rural Wisconsin, November 2020 to December 2021

2020년 11월부터 2021년 12월까지 위스콘신 시골 지역의 예비 커뮤니티 코호트에서 SARS-CoV-2 감염에 대한 mRNA COVID-19 백신 효과

Article

Published on 2022-07-012022-09-11
Journal: Influenza and Other Respiratory Viruses [Category] COVID19(2023년), SARS, 변종,